Patent urachus

disease
On this page

Also known as patent urachus (disease)

Summary

Patent urachus (MONDO:0018551) is a disease. A subtype of congenital urachal anomaly — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Prevalence: 1-9 / 100 000 (United States) [Orphanet-validated]
  • Phenotypes (HPO): 10

Clinical features

Epidemiology

Prevalence records

1 prevalence record(s), Orphanet:

TypeClassValueGeographyValidation
Prevalence at birth1-9 / 100 0001.75United StatesValidated

Signs & symptoms

Clinical features (HPO)

10 HPO clinical features (Orphanet curated; top 10 by frequency):

HPO IDTermFrequency
HP:0010479Patent urachusVery frequent (80-99%)
HP:0010881Abnormality of the umbilical cordVery frequent (80-99%)
HP:0000010Recurrent urinary tract infectionsFrequent (30-79%)
HP:0002027Abdominal painFrequent (30-79%)
HP:0012618Urachal cystFrequent (30-79%)
HP:0034267Pelvic painFrequent (30-79%)
HP:0100645CystoceleFrequent (30-79%)
HP:0005420Recurrent gram-negative bacterial infectionsOccasional (5-29%)
HP:0010957Congenital posterior urethral valveOccasional (5-29%)
HP:0032435Neonatal omphalitisOccasional (5-29%)

Identifiers

Disease identifiers

FieldValue
Canonical namepatent urachus
Mondo IDMONDO:0018551
Orphanet431341
ICD-111391202028
NCITC99005
SNOMED CT398316009
UMLSC0266357
MedGen75610
GARD0021798
Is cancer (heuristic)no

Also known as: patent urachus · patent urachus (disease)

Data availability: 1 HPO phenotype.

Disease family

This is a subtype of congenital urachal anomaly. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › urinary system disordercongenital urachal anomalypatent urachus

Related subtypes (3): urachal sinus, urachal diverticulum, urachal cyst

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.